WHO: Widely Available Treatments Keeping Malaria under Better Control

A WHO report says one-third of the 108 countries, where malaria was endemic, were on course to eradicate the disease within ten years.
According to the World Malaria Report 2010 released by the World Health Organisation (WHO), the number of deaths caused by malaria has decreased by more than 20% worldwide over the last decade, thanks to improved diagnostic testing and the increased availability of treatments.
The report noted there were 225 million cases of malaria and an estimated 781,000 deaths in 2009, a decrease from 233 million cases and 985,000 deaths in 2000.
Information from manufacturers indicates the number of Artemisinin-based combination therapies (ACTs) procured has increased every year since 2005 and by the end of 2009, 11 African countries were providing sufficient courses of ACTs to cover more than 100% of malaria cases seen in the public sector.
Related News
-
News Bringing the pharmaceutical supply chain closer to home
The pharmaceutical supply chain has encountered numerous disruptions in the last few years, impacting procurement, manufacturing, packaging, and distribution operations within the pharmaceutical industry. Read about the rise in calls for near/resh... -
News Women in Pharma: Advancing gender diversity & healthcare equality
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Humira biosimilars at discounted prices to meet market demand for accessible treatment
Several biosimilars to AbbVie’s monoclonal antibody therapeutic Humira were launched by various pharmaceutical giants this week in the US, with more expected to be released by the end of the year as the patent expires. -
News Women in Pharma: Gearing up for systemic change
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Delivering on mRNA-based therapeutics: innovations in applications and packaging
Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet... -
News Novavax will provide adjuvant Matrix-M for vaccine research with 3-year partnership
Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research. -
News CPHI Online Webinar Series – The CPO Perspective: Driving Healthcare Sustainability
Pharmaceutical contract packaging organisations (CPOs) offer organisations broader expertise in pharma packaging, specialist skills, and flexibility with time, efficiency, and costings for pharmaceutical companies lacking in-house packaging expert... -
News The CPO Starter Pack: Why and When to Bring in a Contract Packaging Partner
Discover the trends affecting the pharmaceutical CPO market, when and why outsourcing may be an enticing option, and what is driving pharmaceutical companies and CDMOs to partner with outsourced packaging and drug delivery organisations. ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance